Michael B. Levy

Michael B. Levy

Policy Director


Michael Levy works on matters involving the executive and legislative branches of the federal government. He also served as a Distinguished Teaching Professor at the Georgetown University School of Business for more than a decade. Michael's practice focuses on financial services, health care, taxes and trade.

Previously, Michael was the assistant secretary of legislative affairs for the U.S. Department of the Treasury and senior advisor to Treasury Secretary Robert Rubin. Responsible for passing the Treasury's legislative agenda into law, he coordinated the activities of the Treasury's legislative affairs staff and the staffs of the Internal Revenue Service; Bureau of Alcohol, Tobacco and Firearms; Financial Management Service; the U.S. Mint; Bureau of Engraving and Printing; Secret Service; Office of the Comptroller of the Currency; and Office of Thrift Supervision. Michael also coordinated the Treasury's legislative agenda with the Office of Legislative Affairs at the White House.

From 1987 to 1993, Michael served as chief of staff to former U.S. Senator Lloyd Bentsen. He worked as a staff economist at the Joint Economic Committee from 1985 to 1987. From 1978 to 1985, Michael was an Associate Professor at Texas A&M University. He was granted tenure in 1984, teaching courses in political science, public policy and political theory.

For more than a decade, Michael served on the board of Panim: Washington Institute for Jewish Leadership and Values, and continues to serve as a commissioner on the U.S. Commission for the Preservation of America's Heritage Abroad. He was appointed by President Clinton and re-appointed by President Bush.


Representative Matters

Recent Experience

  • Lobbied Congress and the White House to defeat a proposed rule from the Department of Labor, which would impose significant changes to our client's business model. We built significant policymaker opposition and the White House removed the rule from consideration.

  • Successfully lobbied the Securities and Exchange Commission to carve out and improve money market rules proposed by the Chair of the SEC, and supported by the Administration.

  • Successfully lobbied the NY Governors Office and state legislature to defeat a proposed budget measure that called for the revocation of a foreign tax credit treaty exemption. The measure would have raised billions by imposing a double tax on global companies paying taxation abroad with countries under an existing treaty.

  • Assisted titanium industry in negotiating new terms for governing the military’s purchase of specialty metals.

  • Prevented the expansion of foreign trade that created a competitive advantage for a rival metals producer.

  • Worked with an aluminum company to defeat unfair state utility legislation.

  • Lobbied Congress to include and reauthorize a "pro-investment provision" that allows businesses to deduct 100% of their equipment expenses to help stimulate the economy and job growth in 2008 and 2010.

  • Helped pass cancellation of indebtedness income legislation in the 2010 stimulus bill.

  • Brownstein worked closely with industry leaders, House Committee on Ways and Means members, Senate Finance Committee members and the Joint Committee on Taxation to solve existing barriers to foreign capital by successfully passing an amendment to the Foreign Investment in Real Property Tax Act (FIRPTA).

  • Assisted a large international health care company in protecting patient access to life-sustaining clotting factor treatments by advocating for a limited increase in mandatory price discounts.

  • Helped garner an exception for "Qualified Mortgages" (i.e., 30 year fixed with 20% down payment, or those with mortgage insurance) from the risk retention provision of the Dodd-Frank bill.

  • Preserving data protections for costly, research intensive, biological pharmaceutical products; ensuring appropriate reimbursement rates for life sustaining products; and including healthy lifestyle initiatives in the Affordable Care Act.

  • During the health care reform debate, helped a major pharmaceutical company successfully advocate for a new FDA-approval pathway for follow-on biologic treatments in a way that preserves the United States' competitive edge in biotechnology while ensuring an appropriate balance between investment in new discovery and containing costs to patients.

  • Worked on behalf of a small biopharmaceutical company to ensure new Medicaid rules would not make it cost-prohibitive to provide its rare-disease medicine to Medicare recipients.

  • Brownstein, along with a coalition of businesses, successfully convinced Congress to pass legislation granting a five-year carryback for net operating losses. This provision helped Fortune 50 companies to redirect billions of dollars for investment and job creation.

  • Helped physician owned hospital retain its governing structure in health care reform.

  • Assisted a small pharmaceutical company in obtaining appropriate reimbursement rates under new health reform law.

  • Successfully worked with the tobacco industry to equalize federal excise tax rates across similar products. This provision helped finance the State Children's Health Insurance Program (SCHIP).

  • On behalf of private equity clients, preserved the controlled company exemption under existing NYSE rule in the Dodd-Frank Wall Street Reform and Consumer Protection Act.

  • Amending the Fair Debt Collection Practices Act to eliminate frivolous lawsuits against private contractors working on behalf of hundreds of America’s district attorneys.



  • Ph.D., 1979, Rutgers University
  • B.A., 1969, Brown University


Board Member, Panim: Washington Institute for Jewish Leadership & Values

Commissioner, U.S. Commission for the Preservation of America’s Heritage Abroad

Community Involvement


Board Member, Solomon Project

Council Member, Dean's Advisory Group, Rutgers University, Graduate School of Arts and Sciences



Distinguished Teaching Award, Georgetown University MBA Program, 1997